These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26108432)

  • 41. Intraoperative microelectrode recording for the delineation of subthalamic nucleus topography in Parkinson's disease.
    Seifried C; Weise L; Hartmann R; Gasser T; Baudrexel S; Szelényi A; van de Loo S; Steinmetz H; Seifert V; Roeper J; Hilker R
    Brain Stimul; 2012 Jul; 5(3):378-387. PubMed ID: 21782543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Electrophysiology of subthalamic nucleus in normal and Parkinson's disease].
    Tai CH; Kuo CC
    Acta Neurol Taiwan; 2006 Sep; 15(3):206-16. PubMed ID: 16995602
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sevoflurane and Parkinson's Disease: Subthalamic Nucleus Neuronal Activity and Clinical Outcome of Deep Brain Stimulation.
    Tsai ST; Tseng GF; Kuo CC; Chen TY; Chen SY
    Anesthesiology; 2020 May; 132(5):1034-1044. PubMed ID: 32044799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NMDA-induced burst firing in a model subthalamic nucleus neuron.
    Kubota S; Rubin JE
    J Neurophysiol; 2011 Aug; 106(2):527-37. PubMed ID: 21562199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implantation of electrodes for deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease with the aid of intraoperative microrecording under general anesthesia.
    Hertel F; Züchner M; Weimar I; Gemmar P; Noll B; Bettag M; Decker C
    Neurosurgery; 2006 Nov; 59(5):E1138; discussion E1138. PubMed ID: 17143204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does probe's eye subthalamic nucleus length on T2W MRI correspond with microelectrode recording in patients with deep brain stimulation for advanced Parkinson's disease?
    Kocabicak E; Aygun D; Ozaydin I; Jahanshahi A; Tan S; Onar M; Boke O; Kurt M; Guz H; Terzi M; Alptekin O; Temel Y
    Turk Neurosurg; 2013; 23(5):658-65. PubMed ID: 24101315
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pallidotomy suppresses beta power in the subthalamic nucleus of Parkinson's disease patients.
    Contarino MF; Bour LJ; Bot M; Van Den Munckhof P; Speelman JD; Schuurman PR; De Bie RM
    Eur J Neurosci; 2011 Apr; 33(7):1275-80. PubMed ID: 21366725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased Power but Preserved Bursting Features of Subthalamic Neuronal Signals in Advanced Parkinson's Patients under Controlled Desflurane Inhalation Anesthesia.
    Lin SH; Lai HY; Lo YC; Chou C; Chou YT; Yang SH; Sun I; Chen BW; Wang CF; Liu GT; Jaw FS; Chen SY; Chen YY
    Front Neurosci; 2017; 11():701. PubMed ID: 29311782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Propofol decreases neuronal population spiking activity in the subthalamic nucleus of Parkinsonian patients.
    Raz A; Eimerl D; Zaidel A; Bergman H; Israel Z
    Anesth Analg; 2010 Nov; 111(5):1285-9. PubMed ID: 20841416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationship between local field potential and neuronal discharge in the subthalamic nucleus of patients with Parkinson's disease.
    Kühn AA; Trottenberg T; Kivi A; Kupsch A; Schneider GH; Brown P
    Exp Neurol; 2005 Jul; 194(1):212-20. PubMed ID: 15899258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinctive neuronal firing patterns in subterritories of the subthalamic nucleus.
    Pozzi NG; Arnulfo G; Canessa A; Steigerwald F; Nickl R; Homola GA; Fato MM; Matthies C; Pacchetti C; Volkmann J; Isaias IU
    Clin Neurophysiol; 2016 Nov; 127(11):3387-3393. PubMed ID: 27669486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The STN beta-band profile in Parkinson's disease is stationary and shows prolonged attenuation after deep brain stimulation.
    Bronte-Stewart H; Barberini C; Koop MM; Hill BC; Henderson JM; Wingeier B
    Exp Neurol; 2009 Jan; 215(1):20-8. PubMed ID: 18929561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subthalamic Single Cell and Oscillatory Neural Dynamics of a Dyskinetic Medicated Patient With Parkinson's Disease.
    Ozturk M; Kaku H; Jimenez-Shahed J; Viswanathan A; Sheth SA; Kumar S; Ince NF
    Front Neurosci; 2020; 14():391. PubMed ID: 32390796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Addition of deep brain stimulation signal to a local field potential driven Izhikevich model masks the pathological firing pattern of an STN neuron.
    Michmizos KP; Nikita KS
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():7290-3. PubMed ID: 22256022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MK801 and amantadine exert different effects on subthalamic neuronal activity in a rodent model of Parkinson's disease.
    Allers KA; Bergstrom DA; Ghazi LJ; Kreiss DS; Walters JR
    Exp Neurol; 2005 Jan; 191(1):104-18. PubMed ID: 15589517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Noradrenergic modulation of subthalamic nucleus activity in human: metoprolol reduces spiking activity in microelectrode recordings during deep brain stimulation surgery for Parkinson's disease.
    Coenen VA; Gielen FL; Castro-Prado F; Abdel Rahman A; Honey CR
    Acta Neurochir (Wien); 2008 Aug; 150(8):757-62; discussion 762. PubMed ID: 18574545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical outcome of subthalamic stimulation in Parkinson's disease is improved by intraoperative multiple trajectories microelectrode recording.
    Reck C; Maarouf M; Wojtecki L; Groiss SJ; Florin E; Sturm V; Fink GR; Schnitzler A; Timmermann L
    J Neurol Surg A Cent Eur Neurosurg; 2012 Nov; 73(6):377-86. PubMed ID: 23042143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subthalamic burst firing: A pathophysiological target in Parkinson's disease.
    Tai CH
    Neurosci Biobehav Rev; 2022 Jan; 132():410-419. PubMed ID: 34856222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Uncoupling the roles of firing rates and spike bursts in shaping the STN-GPe beta band oscillations.
    Bahuguna J; Sahasranamam A; Kumar A
    PLoS Comput Biol; 2020 Mar; 16(3):e1007748. PubMed ID: 32226014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease.
    Priori A; Foffani G; Pesenti A; Tamma F; Bianchi AM; Pellegrini M; Locatelli M; Moxon KA; Villani RM
    Exp Neurol; 2004 Oct; 189(2):369-79. PubMed ID: 15380487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.